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Abstract
Techniques based on nuclear magnetic resonance (NMR) for imaging and chemical analyses of in vivo, or
otherwise intact, biological systems are rapidly emerging and finding diverse applications within a wide range
of fields. Very recently, several NMR-based techniques have been developed for the zebrafish as a model
animal system. In the current study, the novel application of high-resolution magic angle spinning (HR-MAS)
NMR is presented as a means of metabolic profiling of intact zebrafish embryos. Toward investigating the
utility of HR-MAS NMR as a toxicological tool, these studies specifically examined metabolic changes of
embryos exposed to polymethoxy-1-alkenes (PMAs)—a recently identified family of teratogenic compounds
from freshwater algae—as emerging environmental contaminants. One-dimensional and two-dimensional HR-
MAS NMR analyses were able to effectively identify and quantify diverse metabolites in early-stage (£36 h
postfertilization) embryos. Subsequent comparison of the metabolic profiles between PMA-exposed and control
embryos identified several statistically significant metabolic changes associated with subacute exposure to the
teratogen, including (1) elevated inositol as a recognized component of signaling pathways involved in embryo
development; (2) increases in several metabolites, including inositol, phosphoryl choline, fatty acids, and
cholesterol, which are associated with lipid composition of cell membranes; (3) concomitant increase in glucose
and decrease in lactate; and (4) decreases in several biochemically related metabolites associated with central
nervous system development and function, including c-aminobutyric acid, glycine, glutamate, and glutamine. A
potentially unifying model/hypothesis of PMA teratogenicity based on the data is presented. These findings,
taken together, demonstrate that HR-MAS NMR is a promising tool for metabolic profiling in the zebrafish
embryo, including toxicological applications.
Introduction
Methods based on the application of nuclear mag-netic resonance (NMR) for imaging (i.e., magnetic
resonance imaging [MRI]) and chemical characterization
(i.e., NMR spectroscopy) of in vivo, or otherwise intact, bi-
ological systems have rapidly evolved within biomedical and
related scientific fields. With respect to imaging, MRI tech-
niques utilize, in particular, the abundance of water in bio-
logical systems, coupled with the detection of the magnetic
nuclear spin of hydrogen (1H) atoms in H2O, to collect high-
resolution spatial data within biological samples and subse-
quently generate resolved, three-dimensional (3D) images.
Conversely, NMR spectroscopy is capable of discerning
particular molecules based, likewise, on the spin of 1H or, in
fact, isotopes of several relevant atoms (e.g., 13C, 15N), and
more exactly, the corresponding chemical shift of a particular
atom within the molecule. When applied to biological sys-
tems and the detection and measurement of metabolites in
particular, NMR spectroscopy can be specifically enabled by
a technique called high-resolution magic angle spinning (HR-
MAS). Briefly stated, spinning of a sample at the so-called
magic angle (54.74) relative to the applied magnetic field
enables averaging of the various interactions (i.e., dipolar,
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quadrupolar, anisotropic), which otherwise broaden chemical
shifts, and thus enables narrowing of signal and consequently
sufficient resolution of metabolites within a complex matrix.
Accordingly, HR-MAS NMR has emerged as a very prom-
ising technique for chemical analysis, including metabolic
profiling, in various biological systems.1
Most recently, various NMR-based techniques for imaging
and chemical analysis (including HR-MAS NMR) have been
reported for the zebrafish as an increasingly important animal
model.2–6 To date, however, NMR has been largely applied to
adult stages of zebrafish, and has enabled in vivo imaging,
and localized chemical analyses, in this system. With respect
to the former, NMR-based microimaging (lMRI) was re-
cently demonstrated with live zebrafish and specifically ap-
plied to the detection and characterization of melanomas.2,3
Localized in vivo high-resolution spectroscopy, likewise, was
achieved in the brain of adult zebrafish (with a spatial reso-
lution of voxels as small as 3.3 lL) and specifically utilized,
as an example, for metabolic profiling of spatially defined
regions of the brain including, most recently, effective lipid
profiling.4,5 Although the past studies have largely focused on
adult stages of the zebrafish, one such study applied NMR,
and HR-MAS specifically, for chemical analysis of intact
embryonic stages and, in particular, was able to quantify
ethanol levels as part of exposure studies.6
In the present study, HR-MAS was investigated as a means
of metabolic profiling of intact zebrafish embryos. As em-
bryonic stages of the zebrafish represent a particularly ver-
satile system with numerous practical advantages, including
capacity for high-throughput analysis, the development of
HR-MAS-based metabolic profiling would represent a po-
tentially powerful metabolomics tool that could, indeed, be
applicable to a wide range of scientific investigations. Among
the potential applications of HR-MAS NMR to the zebrafish
model is toxicological utility for understanding metabolic
changes related to environmental toxins toward both under-
standing toxicity (i.e., targets, mechanism of action) and
identifying potential biomarkers of exposure. Bolstering this
potential, the zebrafish has, indeed, been utilized extensively as
a toxicological model for a wide array of toxic environmental
contaminants, including heavy metals, endocrine disruptors,
and various organic pollutants.7–9 In particular, embryonic and
subsequent larval stages have proven particularly useful for
characterizing teratogenicity (i.e., developmental toxicity).8,9
With respect to the current study, the zebrafish embryo terato-
genicity assay (ZETA) has been specifically used in the inves-
tigation of toxic, and specifically, teratogenic metabolites from
marine and freshwater algae, including cyanobacteria,10 and has
enabled both characterization of known algal toxins11–13 and
identification (through screening, bioassay-guided isolation,
and chemical/toxicological characterization) of otherwise un-
known toxic metabolites.14–16
In one such study, ZETA was used to identify a family of
teratogenic secondary metabolites, namely, the polymethoxy-
1-alkenes (PMAs), and subsequently demonstrate a taxo-
nomically widespread distribution of these metabolites
among both prokaryotic cyanobacteria and eukaryotic algae
(i.e., Chlorophyta or green algae).14,16 Accordingly, it was
suggested that PMA may represent an emerging class of en-
vironmental toxins specifically associated with increasingly
frequent and intense blooms of so-called harmful algae
worldwide. In fact, PMAs have been previously described
from a wide range of cyanobacteria for more than three de-
cades.17–20 However, only recently have they been linked to
biological activity and specifically observed teratogenicity in
the zebrafish embryo model.14 As such, no data currently exist
with respect to possible mechanisms, or biochemical, mo-
lecular, or cellular targets, of these compounds.
Elucidating the effects of toxic compounds, such as the
PMAs, at the biochemical and molecular level is not only ob-
viously fundamental to understanding the mode of action but
also potentially informative with respect to the assessment of
toxic potential through identification of measurable biomarkers
of exposure. Accordingly, in the current study, HR-MAS NMR
was applied to metabolic profiling of zebrafish exposed to
PMAs, at specifically subacute concentrations and exposure
times, as a means of identifying relevant metabolic changes
toward generating hypothesis regarding mechanisms/targets
of these compounds, as well as potential biomarkers, and as
a model class of compounds demonstrating, more generally,




The teratogenic PMA variant, 4,6,8,10,12,14,16,18,20-
nonamethoxy-1-pentacosene (Fig. 1)—as the typically most
abundant congener—was isolated from cultures of the cya-
nobacterial species, Cylindrospermopsis raciborskii, as pre-
viously described.14,16 Briefly, freeze-dried biomass was
twice extracted in chloroform and pooled extracts (following
filtration) concentrated to dryness in vacuo. Subsequently,
the PMA was isolated by silica gel (60 Å, 40–63 lm) with a
gradient of ethyl acetate in hexane (eluting with 100% ethyl
acetate) and subsequent reverse-phase HPLC (Phenomenex
Luna 5 lm C18 100 Å, 250 · 4.6 mm), using a gradient of
50%–100% acetonitrile (and water).
Exposure of zebrafish to PMA
Zebrafish were exposed to PMA by a method modified
from previously published protocols.10,11,13–16 Briefly, 100
embryos (12 h postfertilization [hpf]) per replicate (n = 4)
were exposed in 35-mm-diameter polystyrene dishes to
20 lg/mL of PMA (in E3 medium21) for 24 h. Exposure
concentration was based on previously determined terato-
genicity of PMA and specifically represent concentrations
that are not acutely toxic (i.e., teratogenic or lethal) to min-
imize metabolic changes associated with mortality or severe
development deformities.14 Likewise, exposure times <36 hpf
(i.e., 12 hpf embryos and 24 h treatment) were selected as
FIG. 1. Structure of 4,6,8,10,
12,14,16.18,20-nonamethoxy-
1-pentacose as a common and
representative PMA. PMA,
polymethoxy-1-alkene.


























































previous studies with PMA-determined teratogenicity, in the
form of morphological deformities, was observed only after
72–96 hpf.14 Control embryos were exposed to the solvent
carrier (i.e., methanol) alone at corresponding (v/v) concen-
trations. Following exposure, treated and control embryos were
washed (to remove any residual PMA) and carefully trans-
ferred to a 4-mm zirconium oxide rotor (Bruker BioSpin
AG), to which 10 lL of deuterated phosphate buffer (100 mM;
pH 7.0) containing 0.1% (w/v) 3-trimetylsilyl-2,2,3,3-
tetradeuteropropionic acid (TSP), as a lock solvent and NMR
(i.e., chemical shift) reference, was added. The rotor was im-
mediately transferred to the NMR spectrometer.
HR-MAS NMR studies
All HR-MAS NMR experiments were carried out on a
Bruker DMX 600 MHz NMR spectrometer operating with a
proton resonance frequency of 600 MHz. The instrument is
equipped with a 4-mm HR-MAS dual inverse 1H/13C probe
with a magic-angle gradient. All measurements were carried
out at a magic-angle spinning rate of 6 kHz and a temperature
of 277 K. Temperature was controlled by a Bruker BVT3000
control unit. Bruker TOPSPIN software (Bruker BioSpin
AG) was used to acquire and process the NMR data.
One-dimensional 1H HR-MAS NMR spectra were re-
corded using rotor synchronized Carr–Purcell–Meiboom–
Gill (CPMG) pulse sequence with water suppression. Each
one-dimensional (1D) spectrum was acquired by applying a
spectral width of 8000 Hz, domain data points 16k, number of
averages 512 with 8 dummy scans, constant receiver gain of
2048, an acquisition time of 2 s, and a relaxation delay of 2 s.
Since NMR measurements were done on intact embryos, the
relaxation delay was set to a small value to remove nascent
short T2 components due to the presence of lipids. All spectra
were processed by an exponential window function corre-
sponding to a line broadening of 1 Hz and zero-filled before
Fourier transformation. 1H HR-MAS NMR spectra were
phased manually and automatically baseline corrected using
TOPSPIN 2.1 (Bruker BioSpin AG). The total analysis time
(including sample preparation, optimization of NMR pa-
rameters, and data acquisition) of 1H HR-MAS NMR spec-
troscopy for each sample was *20 min.
Two-dimensional homonuclear correlation spectroscopy
(1H-1H COSY) was performed in magnitude mode. The pa-
rameters used for COSY were 2048 data points collected in
the t2 domain over the spectral width of 4k; 512 t1 increments
were collected with 16 transients, relaxation delay of 2 s,
acquisition time of 116 ms, and presaturated water resonance
during relaxation delay. The resulting data were zero-filled
with 2048 data points and were weighted with the sine bell
window functions in both dimensions before Fourier Trans-
formation.
Data analysis
For quantification of metabolites, NMR data analysis was
performed using MestReNova software version 6.0.3-5604
(Mestrelab Research S.L.). The concentrations of the various
metabolites in the spectra were determined by comparing
the integral peak intensity of the metabolite of interest with
that of the TSP peak, after correcting for the number of
contributing protons and for tissue weight. All statistical
analyses (t-tests and ANOVAs) of the NMR quantification
results were performed with OriginPro v. 8. F-values were
calculated, and F-values larger than 2.8 ( p < 0.05) were
considered significant.
Multivariate statistical analysis (i.e., principle component
analysis [PCA]) of primary metabolites in the spectra was
performed using Bruker software package AMIX (version
3.8.6). The CPMG spectra, collected from embryos, were
subdivided in the range between 0.3 and 9 ppm into buckets
of 0.04 ppm (total 218 buckets), using Bruker AMIX soft-
ware (version 3.8.7; Bruker GmbH). The region of 4.80–
6.00 ppm was excluded from the analysis to remove the water
signal. To compensate for the differences in the overall me-
tabolite concentration between individual samples, the data
obtained were mean centered, scaled to unit variance, and
then normalized by dividing each integral of the segment
by the total area of the spectrum. The resulting data matrix
was exported into Microsoft Office Excel (Microsoft Cor-
poration). This was then further imported into SIMCA soft-
ware (Umetrics AB) for PCA. Correlation coefficients with
p < 0.05 were considered statistically significant.
Results
A representative 1D 1H HR-MAS NMR spectrum obtained
directly from intact, control zebrafish embryos (12 hpf) is
shown in Figure 2. Highly resolved spectra were obtained, and
the assignment of the metabolites was further reinstated by
comparing the 1H spectra of reference compounds to existing
literature values.22,23 The reference compounds in the Biolo-
gical Magnetic Resonance Data Bank24 were specifically used
for the characterization of the metabolites. For further unam-
biguous assignment of the metabolite resonances in zebrafish
embryos, a two-dimensional (2D), homonuclear (1H-1H),
dipolar-correlation NMR spectrum was measured from intact
embryos (Fig. 3). The 2D spectrum allowed separation of most
overlapping peaks for the coupled spin systems that gave rise to
off-diagonal peaks. The 2D NMR clearly reveals separate
correlation networks of several metabolites and, on the basis of
cross-peaks, unambiguous assignments were made (Fig. 3).
The detailed description of all the peaks’ assignment of me-
tabolites is given in Table 1.
Comparison of 1D HR-MAS spectra obtained from control
and PMA-treated zebrafish embryos is depicted in Figure 4.
Quantitative analysis of metabolites in embryos exposed to
PMA when compared to control embryos shows statistically
significant changes in several identified metabolites in ex-
posed embryos (Fig. 5). The major changes include (1) in-
creased levels of glucose (Glc), (myo-)inositol (m-Ins),
cholesterol (Chol), fatty acids (FA) and phosphoryl choline
(PC) and (2) decreased levels of glutathione (GSH), lactose
(Lac), c-aminobutyric acid (GABA), glycine (Gly), gluta-
mate (Glu), and glutamine (Gln). There were no observable
effects (data not shown) of the PMA at the concentration and
exposure time tested, with respect to mortality, developmental
deformities, or other relevant endpoints (e.g., hatching rate)
that were previously observed at higher concentrations
(‡50 lg/mL) and longer exposure times (>72 hpf) for the
compound.14
The 1H HR-MAS spectra were investigated by PCA, and
subsequent partial least square discriminant analysis (PLS-
DA) modeling (R2 = 0.995, Q2 = 0.999) to probe if control and
PMA-treated embryo can be discriminated, and to determine


























































the spectral regions and corresponding compounds mainly
responsible for separation. The PLS-DA scores plot and
loading plot are presented in Figure 6. The score plot explains
82.4% of total variance of control sample clustering in the
negative PC1 scores and PMA-treated samples in the positive
PC2 scores (Fig. 6A). To determine the variables, that is,
metabolites assigned to the corresponding buckets that are
mainly responsible for the separation of two groups, the load
values or weights of the PC1 were analyzed (Fig. 6B). Signals
coming from m-Ins, PC, Glc, Chol, and FA have a positive
score in the PC1 loading plot within 95% significance in-
terval ( p < 0.05), and signals coming from GABA, Glu, and
Lac have a negative score in the PC1 loading plot. All of these
metabolites have loading within 95% confidence level
FIG. 3. Two-dimensional [1H-1H]
homonuclear correlation HR-MAS
NMR spectrum obtained from intact
zebrafish embryos (12 h post-
fertilization). The 1H shift was
calibrated using TSP as an internal
standard. PC, phosphoryl choline;
Leu, leucine; Thr, threonine.
FIG. 2. One-dimensional 1H HR-
MAS NMR obtained from intact
zebrafish embryos (12 h post-
fertilization). All HR-MAS NMR
measurements are done at 4C with
a spinning speed of 6 kHz, cycle
delay of 2 s, and total number of
scan 256. Water suppression was
done for obtaining enhanced sig-
nals from metabolites. 1H shift was
calibrated using TSP as an internal
standard. Glc, glucose; Lac, lactate;
Ala, alanine; Gln, glutamine; Glu,
glutamate; Gly, glycine; Tau, taurine;
m-Ins, (myo)-inositol, Cho, choline;
tCr, total creatine; GABA, c-
aminobutyric acid; Asp, aspartate;
GSH, glutathione; Ile, isoleucine;
Chol, cholesterol; FA, fatty acid; HR-
MAS, high-resolution magic angle
spinning; NMR, nuclear magnetic
resonance; TSP, 3-trimetylsilyl-
2,2,3,3-tetradeuteropropionic acid.


























































indicating them to be the most significant metabolites for
group separation in the score plot.
Discussion
The current study is the first report of HR-MAS NMR as a
means of metabolite profiling in the intact zebrafish embryo
system (i.e., without any extraction) and generally demon-
strates the technique to be an effective and potentially pow-
erful tool for metabolomics studies of early (e.g., £36 hpf)
developmental stages of this particularly versatile system.
Building on previous work and prior NMR-based character-
ization of the most abundant metabolites found in zebrafish
embryos, 2D homonuclear (i.e., COSY) HR-MAS NMR was
capable of identifying a wide range of relevant metabolites.
Subsequent quantitation of peak area, coupled to PCA, en-
abled statistical analysis of changes in metabolite profiles.
To explore the applicability of HR-MAS NMR metabolite
profiling as a toxicological tool, the technique was specifi-
cally applied to the algal-derived PMAs as taxonomically
widespread potential contaminants of aquatic systems. Al-
though teratogenicity (i.e., morphological deformities) of
PMAs in the zebrafish embryo model has been described,14
the mechanism of this toxicity and possible biochemical,
molecular, and cellular targets remain currently unknown.
Consistent with subacute concentrations and exposure times,
no discernible effects on development (e.g., mortality, de-
formities, hatching rates) were observed. However, embryos
exposed to PMA were, indeed, characterized by statistically
significant changes in several relevant metabolites. More-
over, the changes in metabolic profile, associated with PMA-
exposure, notably demonstrate a possible convergence of
several interrelated biomarkers, which point to a potentially
unifying model of the teratogenicity of these compounds.
As one of the most salient observations, particularly in
light of the teratogenicity of the PMAs, inositol levels were
found to increase significantly in exposed embryos. Deri-
vatives of m-Ins, and phosphatidylinositol derivatives, in
particular, have an established role in Wnt-mediated path-
ways of embryo development (including zebrafish).25,26 Wnt
pathways are a well-described group of signal transduction
pathways that regulate crucial aspects of cell-fate determi-
nation, cell migration, cell polarity, morphological pat-
terning, and organogenesis during embryonic development.
Phosphatidylinositol-based signaling is recognized to serve
as a key intracellular function in this regard.27 Consistent
with a possible role of the Wnt pathway is not only PMA
teratogenicity in general but also specific inhibition of or-
ganogenesis observed in prior studies; more specifically,
exposure to PMAs was found to inhibit the formation of both
the eye and heart in developing embryos,14 and both cardiac
and ocular development in the zebrafish are, indeed, linked
to Wnt.28,29 It is tempting, therefore, to hypothesize a role
for inositol through Wnt pathways in the observed terato-
genicity of PMAs.
An alternative hypothesis conversely, however, might
implicate a more general interaction of PMA with lipids
present in cell membranes. Consistent with this hypothesis, a
concurrent increase in FA, PC, and Chol was observed for
PMA-exposed embryos. These latter metabolites are clearly
associated with lipid composition of cell membranes: PC as
the ‘‘polar head’’ of many phospholipids and FAs as ‘‘non-
polar tails,’’ whereas cholesterol has an established role in
maintaining cell membrane integrity and fluidity, and can
comprise, in fact, as much as 50% cell membranes. Similarly,
inositols (and m-Ins specifically) are components of—and, in
turn, are derived from hydrolytic cleavage of—several
phospholipids of membranes, including phosphatidylinosi-
tols involved in the Wnt pathways.
As such, the combined observation of elevated levels of
these four metabolites by HR-MAS may represent a con-
vergence of indicators reflecting possible interactions of
PMA with membrane lipids and subsequent disruption of
membranes. It has, in fact, been previously proposed based
on 3D modeling that PMAs—and the repetitively poly-
methoxylated backbone, in particular, which forms a hy-
drophobic ‘‘corkscrew’’-like conformation—might interact
with lipids and consequently disrupt membranes.30 Accord-
ingly, disruption of cell membranes could be postulated to
potentiate consequent hydrolysis of phospholipids (through
access to phospholipases) and consequent release (i.e., in-
tracellular elevation) of free PC, m-Ins, and FA. Simulta-
neously, increased synthesis or, alternatively, release from
lipoproteins of cholesterol might, in turn, serve a compen-
satory response to restore membrane integrity. The increased
synthesis of cholesterol as a mechanism to maintain
Table 1. 1H Chemical Shift Assignment




Alanine Ala 2CH 3.7680
3CH3 1.4655
Aspartate Asp 2CH 3.8867
3CH2 2.8021
2.6508
GABA GABA 2CH2 3.0082
4CH2 2.2828
3CH2 1.8888
Choline Cho N(CH3)3 3.1890
Creatine Cr 2CH2 3.9110
N(CH3) 3.0260
b-Glucose Glc 1CH 4.630
2CH2 3.230
Glutamate Glu 2CH 3.7444
4CH2 2.3354
Glutamine Gln 2CH 3.7625
4CH2 2.4350
3CH2 2.1360
Glycine Gly 2CH 3.5450
Myo-inositol m-Ino 4,6CH 3.6114
5CH 3.2652
Scyllo-inositol s-Ino 1–6CH 3.3340
Lactate Lac 2CH 4.0908
3CH3 1.3125
Phosphocreatine PCr 2CH2 3.9260
N(CH3) 3.0280
Taurine Tau 1CH 3.4190
2CH 3.2473
Threonine Thr 4CH3 1.3169
Tyrosine Tyr aCH 3.9299


























































homeostasis has, in fact, precedence in the study of alkyl-
phospholipids which, as proposed for PMA, interact with,
and consequently, disrupt membranes.31
Another compelling observation in our study is the sig-
nificant decrease in several interrelated metabolites associ-
ated with neuronal function and development. Among these,
there is a decrease in Lac concurrent with observed increases
in Glc. Numerous studies suggest that lactate produced from
glucose through glycolysis in supporting glial cells (i.e.,
astrocytes, oligodendrocytes)—and supplied, in turn, to neu-
rons through the so-called astrocyte-neuron lactate shuttle—is
the primary energy source for neurons.32–35 It has been, fur-
thermore, shown that consumption of energy, in the form of
lactate, is particularly important during neuronal development.
FIG. 4. Effect of PMA treatment
on the metabolic profile of intact
zebrafish embryos measured by one-
dimensional 1H HR-MAS NMR.
Representative spectra were ob-
tained after treatment of zebrafish
embryos (12 h postfertilization) for
24 h with (A) either solvent carrier
(control) or (B) PMA, followed by
washing three times with buffer. All
HR-MAS NMR measurements are
done at 4C with a spinning speed of
6 kHz, cycle delay of 2 s, and total
number of scan 256. Water suppres-
sion was done for obtaining en-
hanced signals from metabolites. 1H
shift was calibrated using TSP as an
internal standard.
FIG. 5. The concentration of metabolites in the zebrafish embryos treated with or without PMA. Zebrafish embryos (12 h
postfertilization) were treated for 24 h with either solvent carrier (control) or PMA, followed by washing three times.
Representatives of metabolites that show decrease (A) or increase (B) in their concentrations, relative to tCr after PMA
treatment. Statistical analyses (t-tests and ANOVAs) of the NMR quantification results were performed with OriginPro v. 8.
Values calculated from eight spectra (**p < 0.001, *p < 0.05).


























































Also, similarly, several lines of evidence suggest that supply of
lactate, as a carbon source (as well as energy source),
is essential to myelinogenesis in glial cells during embryo de-
velopment.36
Consistent with reduced glycolysis is decreased levels of
GSH. As a key detoxifying molecule, glutathione is partic-
ularly important for removing reactive oxygen species and
other cytotoxic species (e.g., methylglyoxal37) generated
during glycolysis. The reduced levels of GSH could, there-
fore, reflect a decreased cellular demand, and thus synthesis,
due to the reduced levels of glycolysis. However, the ob-
served reduction in GSH could alternatively, or additionally,
be explained (as discussed below) by depletion due to de-
creased levels of key biosynthetic precursors (i.e., glutamate,
glycine) of this tripeptide.
Aligned with proposed effects of PMA on central nervous
system (CNS) development, simultaneous decreases in Gly,
Glu, Gln, and GABA (as key biomarkers of neuronal func-
tion and development) were observed. Glutamate is the most
abundant and important excitatory neurotransmitter in the
brain, whereas GABA and glycine are the most abundant
inhibitory neurotransmitters in the brain and spinal cord/
brain stem, respectively. Accordingly, the three metabolites
are essential mediators of neuronal activity in the adult
brain, but known to play, in addition, a key role in CNS
development.38–40 Glutamine, conversely, is a well-known
intermediary of GABA and glutamate recycling by way of
the so-called glutamate/glutamine cycle between glia and
neurons.41 Similarly, glial cells are recognized to play a key
role in the cycling of glycine; specifically, astrocytes function
both in the uptake of glycine from synapses and, in turn,
supply glycine and L-serine (as a biosynthetic precursor of
glycine) to neurons.42 Furthermore, aside from their well-
known roles in CNS function and development, glutamate and
glycine are biosynthetic precursors of glutathione, and de-
creases in the two could, therefore, additionally explain the
observed GSH decrease. Indeed, it has been well established
that reduction in the precursors (i.e., glutamate, glycine, and
cysteine) can, in fact, lead to cellular depletions of GSH in glia
and neurons.43
These convergent findings, taken together at the cellular
level, may specifically point to a possible role of myelogenic
glial cells of the developing zebrafish embryo with respect to
the developmental toxicity of PMAs. Implicating a possible
involvement of myelinogenic glia in the observed PMA tox-
icity, cholesterol, and phospholipids (containing either PC,
e.g., sphingomyelin or inositol), which are, as discussed above,
elevated in the PMA-exposed embryos are essential compo-
nents of myelin. In addition, glial cells—and particularly
astrocytes—have an established role in both energy supply
(glycolysis) to neurons and recycling of glycine, glutamate, and
GABA (as discussed above) to neurons.32–35,41,42 Moreover,
glial cells are specifically derived from neural crest cells within
developing embryos and represent a particularly compelling
target for PMAs. In parallel to observed effects on CNS
biomarkers, Wnt pathways (as a possible target of PMAs,
FIG. 6. (A) Partial least square
discriminant analysis score plots
and (B) loading plot of embryos
after treatment with either solvent
carrier (control) or PMA for 24 h.
Loading plots show assigned peaks
from metabolites responsible for
clustering in the score plot.


























































see above) are well known to control neural crest cell fate (i.e.,
differentiation and migration),44 including subsequent role
in the development of eye and heart, which are observably
affected in the acute teratogenicity of PMAs.14 Similarly, one
of the additional hallmarks of the developmental toxicity of
PMAs is lack of development of melanophores which are,
likewise, derived from the neural crest through Wnt.45
Taken together, therefore, the metabolic profile of PMA-
exposed embryos would be consistent with a general unifying
model, through which cell-specific effects of the PMAs, and
particularly, impairment of neural crest (i.e., myelogenic
glial) cells through interference with Wnt pathways, could
explain observed changes, including (1) elevated free PC, m-
Ins, and FA, following proposed disruption of cell mem-
branes and subsequent hydrolysis of phospholipids, along
with concomitant compensatory increases in Chol synthesis
and/or uptake; (2) increased m-Ins specifically consistent
with interference of phosphatidylinositol signaling in Wnt-
based pathways, including in particular, determination of
neural crest cell fate; (3) decreased Lac/increased Glc in-
dicative of reduced glycolysis in glia which, otherwise,
support both myelogenesis and energy demands of neurons;
and (4) consequently decreased GABA, Gly, Glu, and Gln
suggestive, in general, of a loss of glial cell viability and/or
function, for example, neurotransmitter recycling, in relation
to CNS development (Fig. 7).
In conclusion, the novel application of HR-MAS NMR to
intact zebrafish embryos was found to be, in general, an
effective technique for metabolic profiling and specifically
a promising approach to identifying potential targets/
mechanisms and biomarkers related to toxic, or otherwise
bioactive, metabolites (as illustrated, in the current study,
by the algal-derived PMAs). Although future experimental
studies are clearly required to confirm the model/hypothe-
ses generated by the current HR-MAS analysis, these
studies do, indeed, demonstrate the considerable potential
of this technique—as a metabolomics tool—for toxicolog-
ical studies with diverse applicability, in particular, to the
zebrafish embryo model.
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